Robotic Versus Laparoscopic Approach for Rectal Cancer Surgery


Colorectal cancer is a common malignancy in Viet Nam. Laparoscopic surgery becomes a standard treatment in many centers. Today, robotic surgery is a new option for treating colorectal cancer with some advantages such as magnified 3D view, precise movements. Answer on safety and feasibility of robotic surgery for colorectal cancer are not available in Viet Nam. Therefore, the investigators conducted a study " Robotic versus Laparoscopic Approach for Rectal Cancer Surgery".

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 4, 2021

Detailed Description

Rectal cancer is a common surgical disease


  • Procedure: Robotic-assisted rectal cancer resection and Laparoscopic rectal cancer resection
    • we perform robotic surgery using the da Vinci Robot System Si version and laparoscopic surgery to treat rectal cancer

Arms, Groups and Cohorts

  • Experimental: Robotic surgery
    • Patients undergoing robotic surgery for removal of rectal cancer.
  • Experimental: Laparoscopic surgery
    • Patients undergoing laparoscopic for removal of rectal cancer

Clinical Trial Outcome Measures

Primary Measures

  • Conversion to open surgery
    • Time Frame: 1 day
    • the rate of conversion to open surgery

Secondary Measures

  • Time of surgery
    • Time Frame: 1 day
    • Time of surgery on the robot compare to laparoscopic surgery

Participating in This Clinical Trial

Inclusion Criteria

  • able to provide written informed consent – Diagnosis of rectal cancer amenable to curative surgery by anterior resection, low anterior resection, ultra-low anterior resection, abdominal perineal resection, staged T1-T4a, N0-2, M0 Exclusion Criteria:

  • Advanced cancer not amenable to curative surgery – patient did not agree to participate in research

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Binh Dan Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: NGUYEN PHUC MINH, Medical Doctor – Binh Dan Hospital
  • Overall Official(s)
    • Hung V Tran, PhD, Study Director, Binh Dan Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.